Study of the pharmacokinetics of various drugs under conditions of antiorthostatic hypokinesia and the pharmacokinetics of acetaminophen under long-term spaceflight conditions.

acetaminophen antiorthostatic hypokinesia etacizine furosemide pharmacokinetics propranolol spaceflight verapamil

Journal

Drug metabolism and personalized therapy
ISSN: 2363-8915
Titre abrégé: Drug Metab Pers Ther
Pays: Germany
ID NLM: 101653409

Informations de publication

Date de publication:
29 Nov 2021
Historique:
received: 07 07 2021
accepted: 10 10 2021
pubmed: 30 11 2021
medline: 30 11 2021
entrez: 29 11 2021
Statut: aheadofprint

Résumé

To study the pharmacokinetics and relative bioavailability of drugs of different chemical structure and pharmacological action under conditions simulating the effects of some factors of spaceflight, as well as the peculiarities of the pharmacokinetics of acetaminophen under long-term spaceflight conditions. The pharmacokinetics of verapamil (n=8), propranolol (n=8), etacizine (n=9), furosemide (n=6), and acetaminophen (n=7) in healthy volunteers after a single oral administration under normal conditions (background) and under antiorthostatic hypokinesia (ANOH), the pharmacokinetics of acetaminophen in spaceflight members under normal ground conditions (background) (n=8) and under prolonged spaceflight conditions (SF) (n=5) were studied. The stay of volunteers under antiorthostatic hypokinesia had different effects on the pharmacokinetics and bioavailability of drugs: Compared to background, there was a decreasing trend in V The data obtained allow recommending the studied drugs for rational pharmacotherapy in the possible development of cardiovascular disease in manned spaceflight.

Identifiants

pubmed: 34844290
pii: dmdi-2021-0159
doi: 10.1515/dmdi-2021-0159
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Références

Blue, RS, Bayuse, TM, Daniels, VR, Wotring, VE, Suresh, R, Mulcahy, RA, et al.. Supplying a pharmacy for NASA exploration spaceflight: challenges and current understanding. NPJ Microgravity 2019;5:14. https://doi.org/10.1038/s41526-019-0075-2.
Blue, RS, Chancellor, JC, Antonsen, EL, Bayuse, TM, Daniels, VR, Wotring, VE. Limitations in predicting radiation-induced pharmaceutical instability during long-duration spaceflight. NPJ Microgravity 2019;5:15. https://doi.org/10.1038/s41526-019-0076-1.
Braddock, M. Ergonomic challenges for astronauts during space travel and the need for space medicine. J Ergon 2017;7:221. https://doi.org/10.4172/2165-7556.1000221.
Eyal, S. How do the pharmacokinetics of drugs change in astronauts in space? Expet Opin Drug Metabol Toxicol 2020;16:353–6. https://doi.org/10.1080/17425255.2020.1746763.
Kast, J, Yu, Y, Seubert, CN, Wotring, VE, Derendorf, H. Drugs in space: pharmacokinetics and pharmacodynamics in astronauts. Eur J Pharmaceut Sci 2017;109S:S2–8. https://doi.org/10.1016/j.ejps.2017.05.025.
Iosim, S, MacKay, M, Westover, C, Mason, CE. Translating current biomedical therapies for long duration, deep space missions. Precis Clin Med 2019;2:259–69. https://doi.org/10.1093/pcmedi/pbz022.
Eyal, S, Derendorf, H. Medications in space: in search of a pharmacologist’s guide to the galaxy. Pharm Res 2019;36:148. https://doi.org/10.1007/s11095-019-2679-3.
Benson, S, Cable, G, Workman, L. Challenges in anaesthesia during space exploration missions. J Aust Soc Aerosp Med 2019;11:1–10. https://doi.org/10.21307/asam-2019-002.
Chancellor, JC, Blue, RS, Cengel, KA, Auñón-Chancellor, SM, Rubins, KH, Katzgraber, HG, et al.. Limitations in predicting the space radiation health risk for exploration astronauts. NPJ Microgravity 2018;4:8. https://doi.org/10.1038/s41526-018-0043-2.
Kohn, FPM, Hauslage, J. The gravity dependence of pharmacodynamics: the integration of lidocaine into membranes in microgravity. NPJ Microgravity 2019;5:5. https://doi.org/10.1038/s41526-019-0064-5.
Wotring, V. Spaceflight pharmacology. In: Barratt, M, Baker, E, Pool, S, editors. Principles of clinical medicine for space flight. New York, NY: Springer; 2019:815–40 pp.
Wotring, VE. Absorption. In: Space pharmacology. SpringerBriefs in Space Development. Boston, MA: Springer; 2012.
Grigoriev, AI, Egorov, AD. General mechanisms of the effects of weightlessness on the human body. Adv Space Biol Med 1992;2:1–42. https://doi.org/10.1016/s1569-2574(08)60016-7.
Cintron, NM, Lane, HW, Leach, CS. Metabolic consequences of fluid shifts induced by microgravity. Physiologist 1990;33(1 Suppl):S16–9.
Kovachevich, IV, Kondratenko, SN, Starodubshev, AK, Repenkova, LG. Pharmacokinetics of tablet and capsule formulations of acetaminophen in conditions of prolonged space flight. Pharm Chem J 2009;43:130–3. https://doi.org/10.1007/s11094-009-0255-6.
Tietze, KJ, Putcha, L. Factors affecting drug bioavailability in space. J Clin Pharmacol 1994;34:671–6. https://doi.org/10.1002/j.1552-4604.1994.tb02022.x.
Goncharov, IB, Kovachevich, IV. The system of rendering medical aid to astronauts. In: Orbital station «Mir»: space biology and medicine. V.1. Medical support of long-term missions. Moscow; 2001.
Du, B, Daniels, VR, Vaksman, Z, Boyd, JL, Crady, C, Putcha, L. Evaluation of physical and chemical changes in pharmaceuticals flown on space missions. AAPS J 2011;13:299–308. https://doi.org/10.1208/s12248-011-9270-0.
Donina, ZA, Baranov, VM, Alexandrova, NP, Nozdrachev, AD. Respiration and hemodynamics in modeling the physiological effects of weightlessness. Saint Petersburg: Nauka; 2013.
Adithan, C, Thangam, J. A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method. Br J Clin Pharmacol 1982;14:107–9. https://doi.org/10.1111/j.1365-2125.1982.tb04944.x.
Goncharov, IB, Kovachevich, IV, Repenkova, LG, Kondratenko, SN, Starodubtsev, AK. Effect of antiorthostatic hypokinesia on acetaminophen pharmacokinetics and its distribution in saliva of healthy volunteers. Pharm Chem J 2009;43:235–8. https://doi.org/10.1007/s11094-009-0288-x.
Cintron, NM, Putcha, L, Parise, CM, Vanderpioeg, JM. Absorption and bioavailability of orally administered acetaminophen during space flight. Aviat Space Environ Med 1990;61:450.
Polyakov, AV, Svistunov, AA, Kondratenko, SN, Kovachevich, IV, Repenkova, LG, Savelyeva, MI, et al.. Peculiarities of pharmacokinetics and bioavailability of some cardiovascular drugs under conditions of antiorthostatic hypokinesia. Bull Exp Biol Med 2020;168:465–9. https://doi.org/10.1007/s10517-020-04732-w.
Ramenskaya, GV, Kondratenko, SN, Krasnykh, LM. Methods of quantitative determination of drugs in the blood plasma of patients by high performance liquid chromatography. In: Clinical pharmacokinetics: theoretical, applied and analytical aspects. Moscow: GEOTAR-Media; 2009.
O’Connell, SE, Zurzola, FJ. A rapid quantitative determination of acetaminophen in plasma. J Pharm Sci 1982;71:1291–4. https://doi.org/10.1002/jps.2600711128.
Bondareva, IB, Budanov, SV, Bunyatyan, ND, Zherdev, VP, Kolyvanov, GB, Kondratenko, SN, et al.. Bioequivalence assessment of drugs. Moscow: Scientific Center Expertise of Medical Applications; 2008.
Miroshnichenko, II, Tyulyaev, II, Zuev, AP. Bioavailability of drugs. Moscow: Gramotey; 2003.
Agafonov, AA, Piotrovskii, VK. M-IND software for evaluation of pharmacokinetic system parameters by the model-independent method of statistical moments. Khim-Farm Zh 1991;25:16–9.
Sergienko, VI, Jelliffe, R, Bondareva, IB. Applied pharmacokinetics: basic provisions and clinical application. Moscow: RAMS Publishing House; 2003.
Luts, RJ, Dedrick, RL, Matthews, HB, Eling, TE, Anderson, MW. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug Metab Dispos 1977;5:386–96.
Kondratenko, SN. The effect of gastroduodenitis on the absorption of glibenclamide, furosemide, lansoprazole, omeprazole, and theophylline. Pharm Chem J 2003;37:282–4. https://doi.org/10.1023/a:1026041412187.
Arzamastsev, AP, Kondratenko, SN, Starodubtsev, AK, Blinkov, IL, Svetyi, LI. Peculiarities of the pharmacokinetics of some cardiovascular drugs in patients with inflammatory disturbances of the large intestine. Pharm Chem J 2003;37:60–2. https://doi.org/10.1023/A:1024073307986.
Gazenko, OG, Grigoriev, AI, Natochin, YV. Water-salt homeostasis and space flight. Probl Kosm Biol 1986;54:1–238.
Gallardo, E, Barroso, M, Queiroz, JA. Current technologies and considerations for drug bioanalysis in oral fluid. Bioanalysis 2009;1:637–67. https://doi.org/10.4155/bio.09.23.
Arzamastsev, AP, Kondratenko, SN, Starodubtsev, AK, Blinkov, IL, Serebrova, SY. Absorption and pharmacokinetics of some antiulcer drugs in patients with gastrointestinal disturbances. Pharm Chem J 2003;37:128–31. https://doi.org/10.1023/a:1024530513207.

Auteurs

Alexey V Polyakov (AV)

Laboratory for the Development of Means and Methods of Medical Care in Extreme Conditions and Telemedicine of the State Scientific Centre of the Russian Federation, Institute of Medical and Biological Problems of the Russian Academy of Sciences, Moscow, Russian Federation.

Andrey A Svistunov (AA)

Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation.

Svetlana N Kondratenko (SN)

Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation.

Irina V Kovachevich (IV)

Laboratory for the Development of Means and Methods of Medical Care in Extreme Conditions and Telemedicine of the State Scientific Centre of the Russian Federation, Institute of Medical and Biological Problems of the Russian Academy of Sciences, Moscow, Russian Federation.

Lyudmila G Repenkova (LG)

Laboratory for the Development of Means and Methods of Medical Care in Extreme Conditions and Telemedicine of the State Scientific Centre of the Russian Federation, Institute of Medical and Biological Problems of the Russian Academy of Sciences, Moscow, Russian Federation.

Marina I Savelyeva (MI)

Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russian Federation.

Evgenia V Shikh (EV)

Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation.

Lidiya Y Badriddinova (LY)

Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation.

Classifications MeSH